"We are Vida Clinical Studies, located in the heart of the medical community in Dearborn, Michigan. We come from a diverse community in Dearborn that strives to give back. We started our private facility in the hopes of aiding the advancement of medical procedures, devices, and medicine. As professionals, our goal is to provide the best possible care while respecting the rights of each and every patient. We believe that our research facility stands out as it was created with the patient in mind and with the intention of providing pharmaceutical companies with the data needed to advance medicine for all."

During the past decade, Vida Clinical Studies conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 8 clinical trials were completed, i.e. on average, 160% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vida Clinical Studies" #1 sponsor was "Allergan" with 3 trials, followed by "Mesoblast, Inc." with 2 trials sponsored, "Millennium Pharmaceuticals, Inc." with 2 trials sponsored, "Sucampo Pharma Americas, LLC" with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vida Clinical Studies" #1 collaborator was "HealthCore-NERI" with 1 trials as a collaborator and "Sucampo Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Vida Clinical Studies" are "Crohn's Disease" (3 trials), "Diabetes Mellitus" (3 trials), "Gastroparesis" (3 trials), "Opioid-Induced Bowel Dysfunction" (2 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "Vida Clinical Studies" in a lesser frequency.

Most popular intervention types in "Vida Clinical Studies" are "Drug" (11 trials), "Other" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Relamorelin" (3 trials), "vedolizumab" (2 trials), "ICS (Inhaled Corticosteroid) (Triple therapy)" (1 trials) and "LABA (Long-Acting Beta Agonist) (Triple therapy)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vida Clinical Studies" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Vida Clinical Studies". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Vida Clinical Studies, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Vida Clinical Studies, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".